Latest Press Releases
More Press Releases
SRAD Investors Have Opportunity to Lead Sportradar Group AG Securities Fraud Lawsuit
NEW YORK, June 1, 2026
Mesabi Metallics Monetizes Portion of Royalty Interest for $265 Million
NASHWAUK, Minn., June 1, 2026
Industry Data Shows How New York LLC Publication Funds Newspapers Across 36 Counties
After 473 LLC publication orders across 36 New York counties, industry data details how Section 206 ties newspaper
RICHMOND INTERNATIONAL AIRPORT CEO CHAMPIONS AI FOR EVERY EMPLOYEE, PARTNERING WITH THINKGOV TO POWER WHEELS UP 2030
Richmond International Airport partners with ThinkGov to deploy AI across its entire workforce, enhancing strategic
Applied Energetics to Participate in the 2026 Morgan Stanley National Security Innovation Summit
Applied Energetics, Inc. (OTCQB:AERG)TUCSON, AZ, UNITED STATES, June 1, 2026 /EINPresswire.com/ — Applied Energetics,
Nxera’s Vamorolone Granted Key Regulatory Designations Supporting Faster Access for Duchenne Muscular Dystrophy Patients in South Korea
Orphan Drug Designation (ODD) recognizes Duchenne muscular dystrophy as a rare disease with significant unmet medical
NATHAN THE CATLADY LAUNCHES THE PURR-FECT FATHER’S DAY GIFT FOR EVERY CAT DAD
Mission-Driven Cat Rescue Brand Drops Limited-Time 25% Off the Gift-Ready Cat Dad Signature Robe, with 10% of Every
ORVANA ANNOUNCES ATTENDANCE AT THE MINING INVESTMENT EVENT IN QUEBEC CITY, CANADA
TORONTO, June 1, 2026
France Signs Historic Two-Mission Agreement with Vast to the International Space Station and Haven-1, Scheduled to be the World’s First Commercial Space Station
Today at the Choose France Summit, created by the President of the French Republic, Emmanuel Macron, Vast announced
Ono Pharma Announces Oral Presentation of New Data from the Phase 2 Clinical Study of ONO-4578 (EP4 antagonist) in Certain Gastric Cancers at the ASCO 2026 Annual Meeting
ONO-4578, an EP4 antagonist, in combination with OPDIVO® and chemotherapy demonstrated a statistically significant